Trade Summary

11 months ago, Sherman Jeffrey Scott, serving as CFO at Neogenomics Inc (NEO), purchased 20,000 shares at $5.62 per share, for a total transaction value of $112,322.00. Following this transaction, Sherman Jeffrey Scott now holds 188,332 shares of NEO.

This purchase represents a 12.00% increase in Sherman Jeffrey Scott's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 6, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, August 6, 2025 at 4:07 PM ET, meaning the disclosure happened on the same day as the trade.

Neogenomics Inc operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.